Aldosterone Blood Pressure | Medical Algorithm

Evaluation

Are you evaluating a patietn who is being treated with an ACE inhibitor or ARB?

Yes

Is the plasma aldosterone concentration higher than before the ACEI or ARB therapy was started?

Yes

Does the patient have evidence of ...

• refractory heart failure or worsening renal function?

Yes

• sodium retention and potassium loss?

Yes

Results

Please fill out required fields.

Results Interpretation and Description References Next Steps

Data complete?

Evaluation appropriate?

Number of findings suggesting aldosterone breakthrough

Does the patient have evidence of aldosterone breakthrough?

MedicalAlgorithms.com APIs

Power Your Solutions with 5,000+ Automated Medical Analytics

Seamlessly integrate our API library of over 5,000 evidence-based medical analytics into your products and workflows. Our APIs help you:

Build custom, automated clinical workflows tailored to your organization's needs.
Enhance your clinical decision support with advanced, evidence-based analytics.
Streamline revenue cycle management by integrating clinical analytics into billing, coding, and compliance processes.
Support payment and pre-approval processes with automated, standardized medical criteria.
Embed proven medical algorithms directly into your systems and services for consistent, high-quality outcomes.

With MedicalAlgorithms.com APIs, you can accelerate innovation, improve efficiency, and deliver more accurate, data-driven care—without reinventing the wheel.

Explore Medal API

Caution: A qualified health practitioner should verify all results.
Keep patient data confidential and comply with all legal requirements.

Please visit our website Medicalalgorithms.com for Description and Interpretation and further algorithms you may want to consider in the next steps of your evaluation. All information should be verified by a qualified health professional, and all use is subject to Medicalalgorithms.com Terms and Conditions. © Copyright Medicalalgorithms.com Limited

Interpretation and Description

References

Next Steps in Evaluation

Diagnosis

Risk Factors
Clinical Diagnosis, Including Family History For Genetics
Imaging Studies
- Systolic Hypertension
Laboratory Tests
Other Testing
Criteria For Diagnosis
Severity, Prognosis, Stage
Complications
Differential Diagnosis And Mimics, Red Flags
Failure Handling, When To Refer
- Indications to Refer Patient with Hypertension to Specialist

Therapy

Options
- Management of Hypertension in African Americans
Selection
- Risk Score of Pocock et al for Death from Cardiovascular Disease in Adults with Raised Blood Pressure
- Indications to Refer Patient with Hypertension to Specialist
Pharmacogenetics
Dosage Adjustments
- Rebound Hypertension on Discontinuation of Beta-Blockers or Other Medications
Diet
- Management of Hypertension in African Americans
Physical And Lifestyle
- Hypertension Lifestyle Modifications
- Blood Pressure Control in Patient with Diabetes Mellitus
Failure Handling And Therapy Escalation
- Causes and Risk Factors for Resistant Hypertension
Prevention

Monitoring

Response To Therapy
Adverse Effects
Overdose And Reversal
- Causes of Secondary Hypertension
Comorbid Conditions

Patient Concerns

Quality Of Life
- Blood Pressure Control in Patient with Diabetes Mellitus
Psychological Response
- White Coat Hypertension

Specialty

Cardiology

Objective

laboratory tests
pharmacogenetics
dosage calculations
response to therapy
comorbid conditions

ICD-10

I10 - Essential (primary) hypertension
I11 - Hypertensive heart disease
I12 - Hypertensive renal disease

Aldosterone Breakthrough in Patient Receiving ACE Inhibitor or ARB Therapy for Hypertension

Purpose: To evaluate a patient for evidence of aldosterone breakthrough during ACE inhibitor or ARB therapy.